D39.8 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. Short description: Neoplasm of uncertain behavior of oth female genital organs.
Neoplasm skin, dermatofibroma protuberans ICD-10-CM D48.5 is grouped within Diagnostic Related Group (s) (MS-DRG v38.0): 606 Minor skin disorders with mcc 607 Minor skin disorders without mcc
Billable codes are sufficient justification for admission to an acute care hospital when used a principal diagnosis. D48.5 is a billable ICD code used to specify a diagnosis of neoplasm of uncertain behavior of skin. A 'billable code' is detailed enough to be used to specify a medical diagnosis.
Categories D37 - D44, and D48 classify by site neoplasms of uncertain behavior, i.e., histologic confirmation whether the neoplasm is malignant or benign cannot be made. neoplasms of unspecified behavior ( D49.-)
A skin neoplasm of uncertain behavior is a skin growth whose behavior can't be predicted. This diagnosis is only reached after your doctor has conducted a biopsy and sent the sample to a pathologist for examination. There's no way to know whether it will develop into cancer or not.
ICD-10 code: D48. 5 Neoplasm of uncertain or unknown behaviour: Skin.
Providers routinely do not have all the information needed to make a final diagnosis. Consequently, an “unspecified” condition is reported while awaiting additional information. “Neoplasm of uncertain behavior” is frequently documented to describe a mass that is awaiting confirmatory biopsy results.
ICD-10-CM Code for Disorder of the skin and subcutaneous tissue, unspecified L98. 9.
A skin neoplasm is an unusual growth on your skin. The word neoplasm is sometimes used interchangeably with cancer, but neoplasms can also be noncancerous. You might also hear neoplasms referred to as tumors. The cells in your skin grow and divide as needed.
D49. 2 - Neoplasm of unspecified behavior of bone, soft tissue, and skin | ICD-10-CM.
Uncertain has a specific meaning in ICD-10. It means that the specimen has been examined by the pathologist and it can't be determined if the neoplasm is benign or malignant. An uncertain neoplasm is reported after the pathologist's report, not when sending the specimen for biopsy.
5 Neoplasm of uncertain behavior of skin should only be used when the pathologist cannot determine if a neoplasm is benign or malignant. It is a specific code to be utilized after a histologic determination has been made, not a code to be used at the time the sample is obtained.
(NEE-oh-PLA-zum) An abnormal mass of tissue that forms when cells grow and divide more than they should or do not die when they should. Neoplasms may be benign (not cancer) or malignant (cancer).
L02. 31 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM L02.
ICD-10 code: L98. 9 Disorder of skin and subcutaneous tissue, unspecified.
Panniculitis. Panniculitis is a group of conditions that causes inflammation of your subcutaneous fat. Panniculitis causes painful bumps of varying sizes under your skin. There are numerous potential causes including infections, inflammatory diseases, and some types of connective tissue disorders like lupus.
Neoplasm of uncertain behavior of other specified female genital organs 1 D39.8 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. 2 Short description: Neoplasm of uncertain behavior of oth female genital organs 3 The 2021 edition of ICD-10-CM D39.8 became effective on October 1, 2020. 4 This is the American ICD-10-CM version of D39.8 - other international versions of ICD-10 D39.8 may differ.
A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere.
A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere.
Neoplasm of uncertain behavior of other specified male genital organs 1 C00-D49#N#2021 ICD-10-CM Range C00-D49#N#Neoplasms#N#Note#N#Functional activity#N#All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.#N#Morphology [Histology]#N#Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes.#N#Primary malignant neoplasms overlapping site boundaries#N#A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned.#N#Malignant neoplasm of ectopic tissue#N#Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified ( C25.9 ).#N#Neoplasms 2 D37-D48#N#2021 ICD-10-CM Range D37-D48#N#Neoplasms of uncertain behavior, polycythemia vera and myelodysplastic syndromes#N#Note#N#Categories D37 - D44, and D48 classify by site neoplasms of uncertain behavior, i.e., histologic confirmation whether the neoplasm is malignant or benign cannot be made.#N#Type 1 Excludes#N#neoplasms of unspecified behavior ( D49.-)#N#Neoplasms of uncertain behavior, polycythemia vera and myelodysplastic syndromes
A dysplastic nevus or atypical mole is a nevus (mole) whose appearance is different from that of common moles. In 1992, the NIH recommended that the term "dysplastic nevus" be avoided in favor of the term "atypical mole".
Inclusion Terms are a list of concepts for which a specific code is used. The list of Inclusion Terms is useful for determining the correct code in some cases, but the list is not necessarily exhaustive.
The ICD-10-CM Alphabetical Index links the below-listed medical terms to the ICD code D48.5. Click on any term below to browse the alphabetical index.
The ICD-10-CM Neoplasms Index links the below-listed medical terms to the ICD code D48.5. Click on any term below to browse the neoplasms index.
This is the official exact match mapping between ICD9 and ICD10, as provided by the General Equivalency mapping crosswalk. This means that in all cases where the ICD9 code 238.2 was previously used, D48.5 is the appropriate modern ICD10 code.
Neoplasm of unspecified behavior of other specified sites 1 D49.8 should not be used for reimbursement purposes as there are multiple codes below it that contain a greater level of detail. 2 The 2021 edition of ICD-10-CM D49.8 became effective on October 1, 2020. 3 This is the American ICD-10-CM version of D49.8 - other international versions of ICD-10 D49.8 may differ.
A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere.
All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm. Morphology [Histology] Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, ...
A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere.
All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm. Morphology [Histology] Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, ...